[go: up one dir, main page]

EA200201138A1 - Пептид, модулирующий рецептор тромбопоэтина - Google Patents

Пептид, модулирующий рецептор тромбопоэтина

Info

Publication number
EA200201138A1
EA200201138A1 EA200201138A EA200201138A EA200201138A1 EA 200201138 A1 EA200201138 A1 EA 200201138A1 EA 200201138 A EA200201138 A EA 200201138A EA 200201138 A EA200201138 A EA 200201138A EA 200201138 A1 EA200201138 A1 EA 200201138A1
Authority
EA
Eurasian Patent Office
Prior art keywords
thrombopoethine
modeling
peptide
receptor
thrombocytopenia
Prior art date
Application number
EA200201138A
Other languages
English (en)
Other versions
EA006423B1 (ru
Inventor
Татьяна Наранда
Леннарт Ольссон
Original Assignee
Плива, Фармацойтска Индустрия, Дионичко Друштво
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Плива, Фармацойтска Индустрия, Дионичко Друштво filed Critical Плива, Фармацойтска Индустрия, Дионичко Друштво
Publication of EA200201138A1 publication Critical patent/EA200201138A1/ru
Publication of EA006423B1 publication Critical patent/EA006423B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Настоящее изобретение относится к новым диагностическим и фармацевтическим композициям для лечения тромбоцитопении.Отчет о международном поиске был опубликован 2002.01.31.
EA200201138A 2000-04-25 2001-04-23 Олигопептид, обладающий биологической активностью модулятора рецептора тромбопоэтина, и способы его применения EA006423B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00108075A EP1149906A1 (en) 2000-04-25 2000-04-25 Thrombopoietin receptor modulating peptide
PCT/EP2001/004553 WO2001080873A2 (en) 2000-04-25 2001-04-23 Thrombopoietin receptor modulating peptide

Publications (2)

Publication Number Publication Date
EA200201138A1 true EA200201138A1 (ru) 2003-06-26
EA006423B1 EA006423B1 (ru) 2005-12-29

Family

ID=8168467

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200201138A EA006423B1 (ru) 2000-04-25 2001-04-23 Олигопептид, обладающий биологической активностью модулятора рецептора тромбопоэтина, и способы его применения

Country Status (24)

Country Link
US (1) US20030181659A1 (ru)
EP (2) EP1149906A1 (ru)
JP (1) JP2003530867A (ru)
KR (1) KR20030009450A (ru)
CN (1) CN1426467A (ru)
AR (1) AR030278A1 (ru)
AU (2) AU6736601A (ru)
BG (1) BG107214A (ru)
BR (1) BR0110383A (ru)
CA (1) CA2407167A1 (ru)
CZ (1) CZ20023517A3 (ru)
EA (1) EA006423B1 (ru)
EE (1) EE200200610A (ru)
GE (1) GEP20063763B (ru)
HU (1) HUP0300559A3 (ru)
IL (1) IL152204A0 (ru)
IS (1) IS6582A (ru)
MX (1) MXPA02010458A (ru)
NO (1) NO20025114L (ru)
PL (1) PL358304A1 (ru)
SK (1) SK15262002A3 (ru)
WO (1) WO2001080873A2 (ru)
YU (1) YU79202A (ru)
ZA (1) ZA200208662B (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003039476A2 (en) * 2001-11-07 2003-05-15 Millennium Pharmaceuticals, Inc. Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874
US7923431B2 (en) 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
BR0314591A (pt) * 2002-09-18 2005-08-09 Ortho Mcneil Pharm Inc Métodos de aumento de plaquetas e produção de célula tronco hematopoiética
CN1739017B (zh) 2002-12-11 2011-04-06 弗罗桑医疗设备公司 用作拭子的基于明胶的材料
EA010016B1 (ru) * 2003-05-12 2008-06-30 Афимакс, Инк. Новые модифицированные полиэтиленгликолем соединения и их применение
BRPI0411166A (pt) * 2003-05-12 2006-07-18 Affymax Inc composto compreendendo uma parcela de peptìdeo, uma parcela espaçadora e uma parcela de polìmero solúvel em água e composição farmacêutica compreendendo tal composto
JP2005187435A (ja) * 2003-12-26 2005-07-14 Otsuka Chemical Co Ltd 血小板産生促進組成物
DE602005022554D1 (de) 2004-01-30 2010-09-09 Ferrosan As Hämostatische sprays und zusammensetzungen
US8021684B2 (en) 2004-07-09 2011-09-20 Ferrosan Medical Devices A/S Haemostatic composition comprising hyaluronic acid
WO2007088849A1 (ja) * 2006-01-31 2007-08-09 Mitsubishi Kagaku Iatron, Inc. 播種性血管内凝固症候群の病態把握方法
RU2545810C2 (ru) 2008-02-29 2015-04-10 Ферросан Медикал Дивайсиз А/С Устройство для ускорения остановки кровотечения и/или заживления ран
BR112013029334B1 (pt) * 2011-05-13 2022-01-18 The University Of Tokyo Método de produção de megacariócitos poliploidizados e método de produção de plaquetas
WO2013131520A2 (en) 2012-03-06 2013-09-12 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
AU2013275758B2 (en) 2012-06-12 2015-03-12 Ferrosan Medical Devices A/S Dry haemostatic composition
CA2912357C (en) 2013-06-21 2019-12-31 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
JP6489485B2 (ja) 2013-12-11 2019-03-27 フェロサン メディカル デバイシーズ エイ／エス 押し出し増強因子を含んでいる乾燥組成物
CA2960309A1 (en) 2014-10-13 2016-04-21 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
US10653837B2 (en) 2014-12-24 2020-05-19 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
WO2017005590A1 (en) 2015-07-03 2017-01-12 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
CN112368028A (zh) 2018-05-09 2021-02-12 弗罗桑医疗设备公司 用于制备止血组合物的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498599A (en) * 1994-01-21 1996-03-12 Amgen Inc. Methods for stimulating platelet production
WO1996040189A1 (en) * 1995-06-07 1996-12-19 Glaxo Group Limited Peptides and compounds that bind to a receptor
US6342220B1 (en) * 1997-08-25 2002-01-29 Genentech, Inc. Agonist antibodies
WO1999042127A2 (en) * 1998-02-24 1999-08-26 Receptron, Inc. Receptor derived peptides as modulators of receptor activity

Also Published As

Publication number Publication date
AR030278A1 (es) 2003-08-20
EE200200610A (et) 2004-08-16
SK15262002A3 (sk) 2003-05-02
CA2407167A1 (en) 2001-11-01
CN1426467A (zh) 2003-06-25
EP1278849A2 (en) 2003-01-29
WO2001080873A3 (en) 2002-01-31
AU2001267366B9 (en) 2005-07-14
HUP0300559A2 (hu) 2003-06-28
HUP0300559A3 (en) 2005-09-28
KR20030009450A (ko) 2003-01-29
PL358304A1 (en) 2004-08-09
IS6582A (is) 2002-10-14
BR0110383A (pt) 2003-01-21
BG107214A (bg) 2003-11-28
AU2001267366B2 (en) 2005-06-30
US20030181659A1 (en) 2003-09-25
ZA200208662B (en) 2003-10-27
EA006423B1 (ru) 2005-12-29
JP2003530867A (ja) 2003-10-21
YU79202A (sh) 2006-01-16
AU6736601A (en) 2001-11-07
IL152204A0 (en) 2003-05-29
NO20025114L (no) 2002-12-18
EP1149906A1 (en) 2001-10-31
MXPA02010458A (es) 2003-06-06
NO20025114D0 (no) 2002-10-24
GEP20063763B (en) 2006-03-10
WO2001080873A2 (en) 2001-11-01
CZ20023517A3 (cs) 2003-10-15

Similar Documents

Publication Publication Date Title
EA200201138A1 (ru) Пептид, модулирующий рецептор тромбопоэтина
EA200300441A1 (ru) Ассоциация антагониста рецептора св1 и сибутрамина, содержащие их фармацевтические композиции и их применение для лечения ожирения
EA200100971A1 (ru) Новые соединения и композиции в качестве ингибиторов протеазы
EA200201214A1 (ru) Замещенные тиоацетамиды
EA200300293A1 (ru) Противовоспалительные конденсированные пирролокарбазолы
EA200300050A1 (ru) Гликопептидфосфонатные производные
BG66085B1 (bg) Фенилаланинови производни
EA200000920A1 (ru) Производные бициклических гидроксамовых кислот
BG66084B1 (bg) Циклопентаноиндоли, състави,съдържащи такива съединения и използването им
EA199901063A1 (ru) Пиперазиновые производные и их применение в качестве противовоспалительных агентов
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
EA200400241A1 (ru) Направленные к мишени мультимерные контрастные вещества, основанные на пептидах
EA200201247A1 (ru) Соединения для лечения болезни альцгеймера
EA200100780A1 (ru) Антагонисты tweak и рецептора tweak и их использование для лечения иммунологических заболеваний
EA200300580A1 (ru) Соединения лактама
EA200300873A1 (ru) Новая соль сукцинат o-десметилвенлафаксина
EA200200479A1 (ru) Новые олигосахариды, их получение и содержащие их фармацевтические композиции
BR0008056A (pt) Pirrolocarbazóis e isoindolonas cìclicas fundidas substituìdas
ATE466860T1 (de) Cgrp-rezeptorantagonisten
EA200301223A1 (ru) Лекарственные формы окскарбазепина
EA199901013A1 (ru) Гели пролонгированного действия
EP1423137A4 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
ATE398630T1 (de) Zyklische conotoxin-peptide
EA200601217A1 (ru) Новые конденсированные пирролокарбазолы
SE9901077D0 (sv) Novel use

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU